Seqster
In Brief This Week: Genetic Signatures, SEngine Precision Medicine, Inex Innovate, More
News items for the week of July 25, 2022.
The startup health data aggregator believes it can provide patient-controlled longitudinal genomic and phenotypic records to researchers and clinicians alike.
Seqster Partners With United BioSource to Enable Decentralized Clinical Trials
Biopharma services company UBC will use Seqster's health data platform to aggregate genomic and other data and provide a patient portal for trial participants.
Seqster, National Pancreas Foundation Partner on Pancreatic Disease Registry
Seqster will aggregate data from DNA tests and other sources to inform and assist research into new treatments for pancreatitis and pancreatic cancer.